Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Incremental Reduction in Risk of Death Associated With Use of Guideline-Recommended Therapies in Patients With Heart Failure: A Nested Case-Control Analysis of IMPROVE HF.

Fonarow GC, Albert NM, Curtis AB, Gheorghiade M, Liu Y, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW.

J Am Heart Assoc. 2012 Feb;1(1):16-26. doi: 10.1161/JAHA.111.000018. Epub 2012 Feb 20.

PMID:
23130115
[PubMed]
Free PMC Article
2.

Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).

Albert NM, Fonarow GC, Yancy CW, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride M, Mehra MR, O'Connor CM, Reynolds D, Walsh MN.

Am Heart J. 2010 Feb;159(2):238-44. doi: 10.1016/j.ahj.2009.11.022.

PMID:
20152222
[PubMed - indexed for MEDLINE]
3.

Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).

Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Inge PJ, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW.

Circulation. 2010 Aug 10;122(6):585-96. doi: 10.1161/CIRCULATIONAHA.109.934471. Epub 2010 Jul 26.

PMID:
20660805
[PubMed - indexed for MEDLINE]
Free Article
4.

Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications.

Atwater BD, Dai D, Allen-Lapointe NM, Al-Khatib SM, Zimmer LO, Sanders GD, Peterson ED.

Am Heart J. 2012 Nov;164(5):750-755.e1. doi: 10.1016/j.ahj.2012.08.002. Epub 2012 Oct 16.

PMID:
23137506
[PubMed - indexed for MEDLINE]
5.

Race and improvements in the use of guideline-recommended therapies for patients with heart failure: findings from IMPROVE HF.

Reynolds D, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Mcbride ML, Inge PJ, Mehra MR, O'Connor CM, Walsh MN, Yancy CW, Fonarow GC.

J Natl Med Assoc. 2012 May-Jun;104(5-6):287-98.

PMID:
22973678
[PubMed - indexed for MEDLINE]
6.

Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF).

Albert NM, Fonarow GC, Yancy CW, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride M, Mehra MR, O'Connor CM, Reynolds D, Walsh MN.

Am J Cardiol. 2010 Jun 15;105(12):1773-9. doi: 10.1016/j.amjcard.2010.01.360. Epub 2010 May 4.

PMID:
20538129
[PubMed - indexed for MEDLINE]
7.

Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.

Yancy CW, Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN.

Am Heart J. 2009 Apr;157(4):754-62.e2. doi: 10.1016/j.ahj.2008.12.016.

PMID:
19332206
[PubMed - indexed for MEDLINE]
8.

Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.

Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN.

Circ Heart Fail. 2008 Jul;1(2):98-106. doi: 10.1161/CIRCHEARTFAILURE.108.772228. Epub 2008 May 28.

PMID:
19808279
[PubMed - indexed for MEDLINE]
Free Article
9.

Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.

Heywood JT, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Gheorghiade M, Inge PJ, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN.

Circ Heart Fail. 2010 Sep;3(5):596-605. doi: 10.1161/CIRCHEARTFAILURE.109.912683. Epub 2010 Jul 15.

PMID:
20634483
[PubMed - indexed for MEDLINE]
Free Article
10.

Equitable improvement for women and men in the use of guideline-recommended therapies for heart failure: findings from IMPROVE HF.

Walsh MN, Yancy CW, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Inge PJ, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Fonarow GC.

J Card Fail. 2010 Dec;16(12):940-9. doi: 10.1016/j.cardfail.2010.07.250.

PMID:
21111983
[PubMed - indexed for MEDLINE]
11.

Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.

Shah B, Hernandez AF, Liang L, Al-Khatib SM, Yancy CW, Fonarow GC, Peterson ED; Get With The Guidelines Steering Committee.

J Am Coll Cardiol. 2009 Feb 3;53(5):416-22. doi: 10.1016/j.jacc.2008.09.045.

PMID:
19179199
[PubMed - indexed for MEDLINE]
Free Article
12.

Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation.

Nieuwlaat R, Eurlings LW, Cleland JG, Cobbe SM, Vardas PE, Capucci A, López-Sendòn JL, Meeder JG, Pinto YM, Crijns HJ.

J Am Coll Cardiol. 2009 May 5;53(18):1690-8. doi: 10.1016/j.jacc.2009.01.055.

PMID:
19406345
[PubMed - indexed for MEDLINE]
Free Article
13.

How well are chronic heart failure patients being managed?

Fonarow GC.

Rev Cardiovasc Med. 2006;7 Suppl 1:S3-11. Review.

PMID:
16955055
[PubMed - indexed for MEDLINE]
14.

Influence of renal function on the use of guideline-recommended therapies for patients with heart failure.

Heywood JT, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN.

Am J Cardiol. 2010 Apr 15;105(8):1140-6. doi: 10.1016/j.amjcard.2009.12.016. Epub 2010 Feb 20.

PMID:
20381667
[PubMed - indexed for MEDLINE]
15.

Associations between outpatient heart failure process-of-care measures and mortality.

Fonarow GC, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Liu Y, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW.

Circulation. 2011 Apr 19;123(15):1601-10. doi: 10.1161/CIRCULATIONAHA.110.989632. Epub 2011 Apr 4.

PMID:
21464053
[PubMed - in process]
Free Article
16.

Strategies to improve the use of evidence-based heart failure therapies.

Fonarow GC.

Rev Cardiovasc Med. 2005;6 Suppl 2:S32-42. Review.

PMID:
15891703
[PubMed - indexed for MEDLINE]
17.

Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.

Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O'Connor CM, Yancy CW, Young J.

Am Heart J. 2004 Jul;148(1):43-51.

PMID:
15215791
[PubMed - indexed for MEDLINE]
18.

Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.

Shah R, Wang Y, Foody JM.

Am J Cardiol. 2008 Jan 15;101(2):217-22. doi: 10.1016/j.amjcard.2007.08.050.

PMID:
18178410
[PubMed - indexed for MEDLINE]
19.

Clinical Effectiveness of CRT and ICD Therapy in Heart Failure Patients by Racial/Ethnic Classification: Insights From the IMPROVE HF Registry.

Ziaeian B, Zhang Y, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW, Fonarow GC.

J Am Coll Cardiol. 2014 Aug 26;64(8):797-807. doi: 10.1016/j.jacc.2014.05.060.

PMID:
25145524
[PubMed - in process]
20.

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS.

Am J Cardiovasc Drugs. 2005;5(6):351-9. Review.

PMID:
16259523
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk